Z 104657A
Alternative Names: Non-antibiotic macrolide - Zambon; Z104657ALatest Information Update: 16 Jul 2016
At a glance
- Originator Zambon Group SpA
- Class Macrolides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Inflammation in Europe (PO)
- 06 Sep 2004 Data presented at the 18th International Symposium of Medicinal Chemistry (ISMC-2004) have been added to the adverse events, pharmacokinetics and Inflammation pharmacodynamics sections
- 29 Jul 2004 Preclinical trials in Chronic obstructive pulmonary disease in Europe (unspecified route)